Previous close | 3.0000 |
Open | 2.2000 |
Bid | 0.0000 |
Ask | 8.7000 |
Strike | 180.00 |
Expiry date | 2025-01-17 |
Day's range | 2.2000 - 7.2000 |
Contract range | N/A |
Volume | |
Open interest | 3 |
In the most recent trading session, Vertex Pharmaceuticals (VRTX) closed at $416.03, indicating a +0.09% shift from the previous trading day.
While CF remains the main area of focus for Vertex Pharmaceuticals (VRTX), it is seeing success in the development of its non-CF pipeline candidates.
Vertex Pharmaceuticals (VRTX) plans to begin a phase I study on VX-407 in autosomal dominant polycystic kidney disease later this month.